AVDL

NASDAQ · Pharmaceuticals

Avadel Pharmaceuticals

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$21.64

+0.01 (+0.05%)

As of Aug 8, 1:34 AM ET ·

Analyst Consensus

Hold

Analysts

High

Coverage

Buy 6 38%

Hold 10 63%

Sell 0 0%

Price Target

Analyst Price Target +437.3% upside

Low Target $84.09

Average Target $116.27

High Target $133.85

Current Price $21.64

Current
$21.64

Target
$116.27

$84.09 $116.27 avg $133.85

Scenario Analysis

Bear Case

$84.09

288.6%

Low target

Base Case

$116.27

+437.3%

Avg target

Bull Case

$133.85

+518.5%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$23.57

-8.2% from high

52-Week Low

$10.79

+100.6% from low

50-Day SMA

$21.51

+0.6% vs SMA

200-Day SMA

$15.56

+39.1% vs SMA

RSI (14)

61.3

Neutral

Target vs 52W High

$116.27

+393.3% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+12.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+15.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.9%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+26.7%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+169.6%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.1%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+188.8%